Table 1. Clinical data and implantation sites.
Patient | Age | Age at onset | MRI | Histology | Number of implanted electrodes | Implantation sites | Procedure |
1 | 21 | 2 | HS (left MTL) | HS type 1a | 8 | AL, ECL, HL, PCL AR, ECR, HR, PCR | sAHE |
2 | 21 | 3 | HS (left MTL) & right frontal FCD | – | 7 | AL, ECL, HL, PH ECR, HR, PCR | DBS |
3 | 34 | 25 | bilateral HS | – | 5 | ECL, HL AR, ECR, HR | DBS |
4 | 48 | 2 | HS (left MTL) | HS (no classification) | 8 | AL, ECL, HL, PCL AR, ECR, HR, PCR | sAHE |
5 | 27 | 1 | right frontal FCD | FCD type IIa | 3 | FAR, TFR, FPR | LE |
6 | 22 | 11 | no lesion | – | 5 | TLL, TBAL, TBPL TBAL, TBPR | – |
Pathologies: FCD focal cortical dysplasia; HS hippocampal sclerosis. Procedures: DBS deep brain stimulation; LE extended lesionectomy; sAHE selective amygdala-hippocampectomy. Implantation sites: AL amygdala left; AR amygdala right; EL entorhinal cortex left; ER entorhinal cortex right; FAR frontal anterior right; FL frontal lobe; FPR frontal posterior right; HL hippocampus left; HR hippocampus right; MTL mesial temporal lobe; PL perirhinal cortex left; PR perirhinal cortex right; TBAL temporal basal anterior left; TBAR temporal basal anterior right; TBPL temporal basal posterior left; TBPR temporal basal posterior right; TR depth frontal right; TLL temporal lateral left.